Back to search
FDAFDA · Food and drugs·Recall number D-0093-2024

Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, Manufactured for: VistaPharm, Inc., Largo, FL 33771, USA, NDC#66689-307-08.

Published November 15, 2023 · Recall initiated: October 26, 2023

Summary

FDA records drug Class III recall D-0093-2024, published November 15, 2023 and initiated October 26, 2023. Recalling firm: VistaPharm LLC; Status: Terminated; Reported quantity: 11,633 bottles; Lot: Lot #: M23400A, M23401A, M23402A, Exp Date. 04/30/2025; M23591A, M23592A, Exp Date. 06/30/2025. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: The adaptor does not fit into the neck of the bottle after reconstitution with water.

What to do

Voluntary: Firm initiated · Letter

Get an email if MYCOPHENOLATE MOFETIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MYCOPHENOLATE MOFETIL
Manufacturer
VistaPharm LLC
Distributor
Nationwide and Saudi Arabia
Lot
Lot #: M23400A, M23401A, M23402A, Exp Date. 04/30/2025; M23591A, M23592A, Exp Date. 06/30/2025.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, Manufactured for: VistaPharm, Inc., Largo, FL 33771, USA, NDC#66689-307-08. recalled?

Yes. FDA published recall D-0093-2024 on November 15, 2023. Reported hazard: Defective Container: The adaptor does not fit into the neck of the bottle after reconstitution with water.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MYCOPHENOLATE MOFETIL.